Iranian Journal Of Pharmaceutical Research创刊于2002年,由Iranian Journal of Pharmaceutical Research出版商出版,收稿方向涵盖医学 - 药学全领域,此期刊水平偏中等偏靠后,在所属细分领域中专业影响力一般,过审相对较易,如果您文章质量佳,选择此期刊,发表机率较高。平均审稿速度 约2月 ,影响因子指数1.8,该期刊近期没...
录用难度:约72.5% 统计分析 影响因子:指该期刊近两年文献的平均被引用率,即该期刊前两年论文在评价当年每篇论文被引用的平均次数 Created with Highcharts 10.0.0年份Iranian Journal of PharmaceuticalResearch近年影响因子Iranian Journal of Pharmaceutical Research近年影响因子2014201520162017201820192020202120220.511.5202....
under simultaneous consideration by another journal. Moreover, Iranian Journal of Pharmaceutical Research will not publish any manuscript unless the chemical structures of all compounds are fully disclosed, either by reference to prior work providing such data or by enclosure of such data in the ...
《伊朗药物研究杂志》(Iranian Journal Of Pharmaceutical Research)是一本以医学-药学综合研究为特色的国际期刊。该刊由Iranian Journal of Pharmaceutical Research出版商创刊于2002年,刊期Quarterly。该刊已被国际重要权威数据库SCIE收录。期刊聚焦医学-药学领域的重点研究和前沿进展,及时刊载和报道该领域的研究成果,致力于...
The Iranian Journal of Pharmaceutical Research (IJPR) is a peer-reviewed multi-disciplinary pharmaceutical publication, scheduled to appear quarterly and serve as a means for scientific information exchange in the international pharmaceutical forum. Specific scientific topics of interest to the journal ...
Iranian Journal Of Pharmaceutical Research IRAN J PHARM RES ISSN:1735-0328 E-ISSN:1726-6890 投稿咨询学术服务 基本信息 BASIC INFORMATION 审稿时间:约2月 出版周期:Quarterly 出版国家或地区:IRAN 创刊:2002 影响因子:1.8 是否预警:否 语言:English
Iranian Journal of Pharmaceutical Research是一本专注于药物研究领域的学术期刊。该期刊旨在报道药物科学、药理学、药剂学、药用化学等方面的最新研究成果、临床实践经验和医学进展,涵盖了药物研发、药物治疗和药物安全等方面。 1.期刊基本信息 研究方向:药学 出版周期:4 issues/year 出版年份:2002 出版国家:IRAN 期刊IS...
The Iranian Journal of Pharmaceutical Research (IJPR) is a peer-reviewed multi-disciplinary pharmaceutical publication, scheduled to appear quarterly and serve as a means for scientific information exchange in the international pharmaceutical forum. Specific scientific topics of interest to the journal inclu...
期刊名称:《Iranian Journal of Pharmaceutical Research : IJPR》 | 2019年第4期 关键词: PLGA; PEI; IVT- mRNA; GFP; Dendritic cells; Nanoparticle; 4.Lipid Nanocapsules for Imatinib Delivery: Design Optimization and Evaluation of Anticancer Activity Against Melanoma Cell Line 机译:用于伊马替尼递送...